Literature DB >> 24503633

Motility abnormalities in irritable bowel syndrome.

Andrew W DuPont1, Zhi-Dong Jiang, Stephen A Harold, Ned Snyder, Greg W Galler, Francisco Garcia-Torres, Herbert L DuPont.   

Abstract

BACKGROUND/AIMS: The intestinal pathophysiology in irritable bowel syndrome (IBS) is largely unknown. The lactulose breath test has been used to identify small bowel bacterial overgrowth in these patients.
METHODS: We studied intestinal transit in patients with IBS using of the SmartPill® (SP) wireless pH/pressure recording capsule and performed lactulose breath tests to look for physiologic abnormalities.
RESULTS: A total of 35/46 (76%) of the IBS patients had prolonged gastric emptying times. Constipation-predominant disease was associated with prolonged gut transit times. The mean hours ± SD for colonic transit time in the constipation group was 71.7 ± 61.1 (n = 13) compared with 22.5 ± 14.9 (n = 14) for diarrhea-predominant and 26.4 ± 21.5 (n = 20) for mixed clinical subtype (p = 0.0010). No correlation between small bowel transit time and abnormal breath hydrogen or methane excretion in the 46 combined patients with IBS was seen.
CONCLUSIONS: Delayed gastric emptying was identified in IBS and in some patients may contribute to at least a component of their symptoms. Constipation-predominant IBS is associated with prolonged gut transit times. Otherwise, transit abnormalities do not appear to be important in IBS. Intestinal transit did not correlate with breath test results.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24503633     DOI: 10.1159/000356314

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  11 in total

Review 1.  Visceral hypersensitivity and electromechanical dysfunction as therapeutic targets in pediatric functional dyspepsia.

Authors:  John M Rosen; Jose T Cocjin; Jennifer V Schurman; Jennifer M Colombo; Craig A Friesen
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-08-06

Review 2.  Early-life stress origins of gastrointestinal disease: animal models, intestinal pathophysiology, and translational implications.

Authors:  Calvin S Pohl; Julia E Medland; Adam J Moeser
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-10-08       Impact factor: 4.052

3.  The effects of eupatilin (stillen®) on motility of human lower gastrointestinal tracts.

Authors:  Seung-Bum Ryoo; Heung-Kwon Oh; Sung A Yu; Sang Hui Moon; Eun Kyung Choe; Tae Young Oh; Kyu Joo Park
Journal:  Korean J Physiol Pharmacol       Date:  2014-10-17       Impact factor: 2.016

Review 4.  Biomarkers of Irritable Bowel Syndrome.

Authors:  Jae Hak Kim; Eugenia Lin; Mark Pimentel
Journal:  J Neurogastroenterol Motil       Date:  2017-01-30       Impact factor: 4.924

5.  Low-FODMAP vs regular rye bread in irritable bowel syndrome: Randomized SmartPill® study.

Authors:  Laura Pirkola; Reijo Laatikainen; Jussi Loponen; Sanna-Maria Hongisto; Markku Hillilä; Anu Nuora; Baoru Yang; Kaisa M Linderborg; Riitta Freese
Journal:  World J Gastroenterol       Date:  2018-03-21       Impact factor: 5.742

Review 6.  Irritable bowel syndrome in children: Current knowledge, challenges and opportunities.

Authors:  Niranga Manjuri Devanarayana; Shaman Rajindrajith
Journal:  World J Gastroenterol       Date:  2018-06-07       Impact factor: 5.742

7.  Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation.

Authors:  Hilde L von Volkmann; Ingeborg Brønstad; Odd Helge Gilja; Rune R Tronstad; Dag Andre Sangnes; Ragnar Nortvedt; Trygve Hausken; Georg Dimcevski; Torunn Fiskerstrand; Kim Nylund
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

8.  The multicomponent medication Spascupreel attenuates stress-induced gut dysfunction in rats.

Authors:  Vassilia Theodorou; Catherine Beaufrand; Sophie Yvon; Guylaine Laforge; Yvonne Burmeister; Andrea Müller; Bernd Seilheimer; Lionel Bueno; Helene Eutamene
Journal:  Neurogastroenterol Motil       Date:  2020-02-14       Impact factor: 3.598

9.  Wei Chang An pill regulates gastrointestinal motility in a bidirectional manner.

Authors:  Sitong Jia; Lijuan Chai; Jing Zhang; Min Zhang; Lin Li; Yaxin Qi; Yafen Pang; Xi Chen; Nana Fan; Lin Wang; Yujing Wang; Jixiang Song; Yingjie Sun; Yi Wang; Lin Miao; Han Zhang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

10.  Mechanism of the Treatment of Irritable Bowel Syndrome with Sini Powder and Tong Xie Yao Fang Decoction Based on Network Pharmacology.

Authors:  Rong Tang; Xiaoqing Peng; Xiaohong Zhou; Zhimin Zheng; Jiayu Yin; Hong Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-01       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.